Hutter JN, Robben PM, Lee C, Hamer M, et al. First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naive adults. Vaccine 2022 Aug 30. pii: S0264-410X(22)01039.
PMID: 36055874